Education
About Us
Working with TipRanks
Follow Us
Koninklijke Philips N.V. (DE:PHIA)
NYSE:PHIA
Earnings Data
Report Date
May 06, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.21Last Year’s EPS
0.24Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveys a broadly positive operational and financial performance: strong Q4 order intake and sales acceleration, substantial margin expansion, robust Personal Health and Connected Care momentum, significant productivity delivered and an active innovation pipeline. These positives are balanced by tangible near‑term headwinds — notably tariffs (annualized impact in 2026), ongoing Respironics‑related legal and regulatory matters, China tender dynamics, and some D&T margin pressure and Q1 phasing risk. Management has mitigations in place (productivity programs, pricing, localization) and a clear guide for 2026 (3%–4.5% sales growth; 12.5%–13% EBITDA margin), which supports confidence in execution despite the known risks.Company Guidance
Strong Q4 Orders and Sales Momentum
Order intake up 7% in Q4 and 6% for full year; comparable sales growth accelerated to 7% in Q4 (full year 2.3% in line with outlook); order book grew 5% year‑on‑year, providing stronger visibility into 2026.
Improved Profitability and Margins
Adjusted EBITDA margin expanded to 15.1% in Q4 (+160 bps year‑on‑year) and to 12.3% for the full year (+80 bps), driven by sales growth, gross margin improvement from innovation and productivity, and favorable mix.
Personal Health Outperformance
Personal Health comparable sales grew 14% in Q4 and 8% for the full year; adjusted EBITDA margin for Personal Health improved to 23% in Q4 (+500 bps) and to 18% for the full year (+130 bps), driven by premium products (OneBlade, DiamondClean, premium shavers) and strong commercial execution.
Connected Care Momentum
Connected Care delivered 7% comparable sales growth in Q4 (3% FY) with Q4 adjusted EBITDA margin at 16.5% (+150 bps) and FY margin crossing double digits to 10.7% (+110 bps); strong North American monitoring and enterprise informatics demand and large strategic partnerships (e.g., Atrium Health, UNC Rex).
Order Strength in Diagnosis & Treatment and Key Wins
Diagnosis & Treatment orders grew (D&T order intake +5% FY) with Image‑Guided Therapy delivering double‑digit growth in Q4; strong demand for Azurion 7, EPIQ CVx ultrasound and CT 5300, and a 10‑year collaboration with Bon Secours Mercy Health across 80+ labs.
Innovation Pipeline and Strategic M&A
Launched helium‑free 3T MRI, Verida (always‑on spectral CT), LumiGuide (AI‑enabled 3D navigation), and closed acquisition of SpectraWAVE (HD intravascular imaging) — expected to support demand, improve mix and contribute to gross‑margin expansion over time.
Material Productivity and Cost Savings Delivered
Delivered EUR 248m productivity savings in Q4 and EUR 815m for the year; over EUR 2.5bn saved since 2023 (exceeding original EUR 2.0bn target); new EUR 1.5bn productivity program launched for 2026–2028.
Improved Earnings, Cash and Leverage
Adjusted diluted EPS from continuing operations of EUR 0.60 in Q4 (+20% YoY) and +15% for the full year; Q4 net income EUR 397m; Q4 free cash flow EUR 1.2bn; year‑end cash ~EUR 2.8bn and net debt ~EUR 5.3bn with leverage improved to 1.7x (net debt/adjusted EBITDA).
DE:PHIA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:PHIA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 10, 2026 | €24.40 | €27.60 | +13.11% |
Nov 04, 2025 | €23.40 | €24.40 | +4.27% |
Jul 29, 2025 | €21.80 | €24.20 | +11.01% |
May 06, 2025 | €21.47 | €20.70 | -3.61% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Koninklijke Philips N.V. (DE:PHIA) report earnings?
Koninklijke Philips N.V. (DE:PHIA) is schdueled to report earning on May 06, 2026, Before Open (Confirmed).
What is Koninklijke Philips N.V. (DE:PHIA) earnings time?
Koninklijke Philips N.V. (DE:PHIA) earnings time is at May 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Koninklijke Philips N.V. stock?
The P/E ratio of Koninklijke Philips is N/A.
What is DE:PHIA EPS forecast?
DE:PHIA EPS forecast for the fiscal quarter 2026 (Q1) is 0.21.
